Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Catalent Inc

0C8
Current price
53.56 EUR -0.22 EUR (-0.41%)
Last closed 59.75 USD
ISIN US1488061029
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Frankfurt Exchange
Capitalization 10 889 654 272 USD
Yield for 12 month +23.48 %
1Y
3Y
5Y
10Y
15Y
0C8
21.11.2021 - 28.11.2021

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies; pDNA, iPSCs, oncolytic viruses, and vaccines; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The Pharma and Consumer Health segment offers formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations; and oral, nasal, inhaled, and topical dose forms. This segment also provides clinical supply services through manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials; and pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for softgel capsule, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions; fill and finish operations for injectable products; and integrated development and product supply chain solutions. It serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was founded in 1933 and is headquartered in Somerset, New Jersey. Address: 14 Schoolhouse Road, Somerset, NJ, United States, 08873

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

60.75 USD

P/E ratio

Dividend Yield

Current Year

+4 381 000 000 USD

Last Year

+4 276 000 000 USD

Current Quarter

+1 301 000 000 USD

Last Quarter

+1 074 000 000 USD

Current Year

+953 000 000 USD

Last Year

+1 060 000 000 USD

Current Quarter

+384 000 000 USD

Last Quarter

+229 000 000 USD

Key Figures 0C8

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 495 000 000 USD
Operating Margin TTM 9.15 %
PE Ratio
Return On Assets TTM 0.04 %
PEG Ratio 2.8698
Return On Equity TTM -25.39 %
Wall Street Target Price 60.75 USD
Revenue TTM 4 381 000 192 USD
Book Value 19.91 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 23.3 %
Dividend Yield
Gross Profit TTM 1 040 000 000 USD
Earnings per share -5.76 USD
Diluted Eps TTM -5.76 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -15.4 %
Profit Margin -23.81 %

Dividend Analytics 0C8

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 0C8

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 0C8

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 53.1915
Enterprise Value Revenue 3.5423
Price Sales TTM 2.4857
Enterprise Value EBITDA -19.8416
Price Book MRQ 3.0215

Financials 0C8

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 0C8

For 52 weeks

31.8 USD 61.2 USD
50 Day MA 58.79 USD
Shares Short Prior Month 10 546 982
200 Day MA 53.94 USD
Short Ratio 4.18
Shares Short 8 527 269
Short Percent 6.02 %

Dynamics of changes in the value of assets

C

CA3

50.50 EUR COMERICA INC - Dusseldorf Stock Exchang +0.99 (+1.81%)
Detailed analytics
E

EMRAF

37.52 USD Emera Incorporated -0.04 (-0.11%)
Detailed analytics
N

NCSYF

165.00 USD NICE Ltd 0 (0%)
Detailed analytics
1

1C9

54.00 EUR CCL Industries Inc 0 (0%)
Detailed analytics
NIO

NIO

5.48 USD Nio Inc Class A ADR +0.05 (+0.92%)
Detailed analytics